Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Eckert & Ziegler Strahlen- und Medizintechnik AG

Start price
Target price
Perf. (%)
€43.36
31.05.22
-
31.05.23
4.47%
11.08.22

buy
Affimed N.V.

Start price
Target price
Perf. (%)
€3.34
22.05.22
-
22.05.23
-68.81%
22.05.23

buy
Vita 34 AG

Start price
Target price
Perf. (%)
€11.05
18.05.22
-
18.05.23
-0.45%
28.05.22

Very Future proof/growth oriented business model
Market Leader or Top 3
Could be very worthwhile Investment >20% year
Rising EBIT margin expected
buy
Biofrontera AG

Start price
Target price
Perf. (%)
€1.16
18.05.22
-
18.05.23
2.59%
28.05.22

Could be very worthwhile Investment >20% year
Undervalued
buy
Drägerwerk AG & Co. KGaA VZO

Start price
Target price
Perf. (%)
€49.25
16.05.22
-
16.05.23
4.16%
11.07.22

buy
Drägerwerk AG & Co. KGaA ST

Start price
Target price
Perf. (%)
€41.80
12.05.22
-
12.05.23
-6.22%
13.05.23

Eckert & Ziegler Strahlen- und Medizintechnik AG

Start price
Target price
Perf. (%)
€50.60
23.04.22
€22.00
23.04.23
-28.85%
20.06.22

buy
Eckert & Ziegler Strahlen- und Medizintechnik AG

Start price
Target price
Perf. (%)
€55.05
18.04.22
-
18.04.23
-21.31%
19.04.23

buy
Drägerwerk AG & Co. KGaA VZO

Start price
Target price
Perf. (%)
€46.50
14.04.22
€54.00
14.04.23
0.43%
12.05.22

buy
Affimed N.V.

Start price
Target price
Perf. (%)
€4.75
11.04.22
-
11.04.23
-41.07%
08.06.22

Could be worthwhile Investment >10% per year
buy
Paul Hartmann AG

Start price
Target price
Perf. (%)
€326.00
04.04.22
-
04.04.23
-31.60%
05.04.23

buy
B.R.A.I.N. Biotechnology Research and Information Network AG

Start price
Target price
Perf. (%)
€9.08
21.03.22
-
21.03.23
-17.18%
25.07.22

buy
Drägerwerk AG & Co. KGaA VZO

Start price
Target price
Perf. (%)
€53.75
16.03.22
-
16.03.23
-8.37%
16.05.22

buy
Mediclin AG

Start price
Target price
Perf. (%)
€3.32
07.03.22
-
07.03.23
0.60%
19.03.22

EBIT growth >5% per year expected
positive Cash Flow expected
Top 10 in its market
Future proof or reliable business model
buy
Affimed N.V.

Start price
Target price
Perf. (%)
€4.14
26.02.22
-
26.02.23
-59.29%
27.10.22

Could be very worthwhile Investment >20% year
buy
Medigene AG

Start price
Target price
Perf. (%)
€3.79
22.02.22
€4.00
22.02.23
-45.05%
23.02.23

Could be worthwhile Investment >10% per year
Significant cyclical dependencies
buy
Medigene AG

Start price
Target price
Perf. (%)
€3.71
22.02.22
€5.00
22.02.23
18.89%
23.02.22

Could be very worthwhile Investment >20% year
Very capable Management
Good culture
Little innovation
Medigene AG

Start price
Target price
Perf. (%)
€2.91
21.02.22
-
21.02.29
-48.45%
11.03.24

Probably not worthwhile Investment
buy
MagForce AG

Start price
Target price
Perf. (%)
€2.37
29.01.22
€2.80
29.01.23
-99.48%
30.01.23

Could be worthwhile Investment >10% per year
buy
Affimed N.V.

Start price
Target price
Perf. (%)
€3.55
23.01.22
-
23.01.23
0.17%
06.02.22

buy
Eckert & Ziegler Strahlen- und Medizintechnik AG

Start price
Target price
Perf. (%)
€90.00
12.01.22
-
12.01.23
-44.82%
13.01.23

buy
Paion AG

Start price
Target price
Perf. (%)
€1.46
08.01.22
€4.00
08.01.23
-6.69%
22.01.22

buy
Eckert & Ziegler Strahlen- und Medizintechnik AG

Start price
Target price
Perf. (%)
€98.65
04.01.22
-
04.01.23
-56.84%
25.08.22

buy
Paion AG

Start price
Target price
Perf. (%)
€1.23
27.12.21
€2.00
27.12.22
-26.75%
08.09.22

Innovative
Future proof or reliable business model
Could be very worthwhile Investment >20% year
Strong uniques
buy
Stratec SE

Start price
Target price
Perf. (%)
€132.00
23.12.21
-
23.12.22
-32.73%
25.08.22